Opsonic monoclonal and chimeric antibodies specific for...

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/08 (2006.01) A61K 39/395 (2006.01) A61K 39/40 (2006.01) C07K 1/00 (2006.01) C07K 16/00 (2006.01) C07K 16/12 (2006.01) C12N 5/12 (2006.01) C12P 21/04 (2006.01)

Patent

CA 2469715

The present invention encompasses monoclonal antibodies that bind to lipoteichoic acid (LTA) of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro. The invention also provides antibodies having human sequences (chimeric, humanized and human antibodies). The invention also sets forth the variable regions of three antibodies within the invention and presents the striking homology between them.

La présente invention concerne des anticorps monoclonaux qui se fixent à l'acide lipotéichoïque de bactéries Gram-positif. Lesdits anticorps se fixent également à ces bactéries et favorisent la phagocytose et la mort desdites bactéries in vitro. L'invention concerne également des anticorps présentant des séquences humaines (anticorps chimériques, humanisés et humains). L'invention concerne en outre des régions variables de trois anticorps et porte sur l'homologie frappante qu'il existe entre eux.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Opsonic monoclonal and chimeric antibodies specific for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Opsonic monoclonal and chimeric antibodies specific for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Opsonic monoclonal and chimeric antibodies specific for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1770479

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.